Advertisement

Topics

Intec Pharma Enters Research Collaboration Agreement With Merck for the Accordion Pill Platform

09:47 EDT 17 May 2019 | Speciality Pharma Journal

NEW YORK, May 16, 2019 /PRNewswire/ –Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces it has entered into an agreement with Merck, known as MSD outside the United States and Canada, to explore using the Accordion Pill® (AP) platform for an undisclosed development program. “We are very excited to collaborate with Merck,” …

Original Article: Intec Pharma Enters Research Collaboration Agreement With Merck for the Accordion Pill Platform

NEXT ARTICLE

More From BioPortfolio on "Intec Pharma Enters Research Collaboration Agreement With Merck for the Accordion Pill Platform"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...